Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Operating Leases (2019 - 2026)

Innoviva's (INVA) quarterly Operating Leases came in at $10.7 million in Q1 2026, up 879.29% YoY from $1.1 million in Q1 2025, and down 1.69% on a QoQ basis from $10.9 million in Q4 2025.

Analysis

Innoviva (INVA) Operating Leases (2019 - 2026) Analysis & Trends

Innoviva (INVA) has 6 years of Operating Leases data on file, last reported at $10.7 million in Q1 2026.

  • Quarterly Operating Leases rose 879.29% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (up 879.29% YoY) and the FY2025 annual result came in at $10.9 million, up 821.8% from the prior year.
  • Operating Leases eased to $10.7 million in Q1 2026, from $10.9 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $10.9 million in Q4 2025 to a low of $905000.0 in Q3 2025.
  • A 5-year average of $2.9 million and a median of $2.0 million in 2023 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2025 — Operating Leases slumped 49.57% — and 2026, when it jumped 879.29%.
  • Tracing INVA's Operating Leases over 5 years: stood at $2.4 million in 2022, then slumped by 31.19% to $1.6 million in 2023, then decreased by 27.89% to $1.2 million in 2024, then jumped by 821.8% to $10.9 million in 2025, then fell by 1.69% to $10.7 million in 2026.
  • The last three Operating Leases figures came in at $10.7 million (Q1 2026), $10.9 million (Q4 2025), and $905000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.49 Mn
Mar 31, 2026 10.68 Mn
Dec 31, 2025 10.87 Mn
Sep 30, 2025 905,000.00
Jun 30, 2025 1.00 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 1.18 Mn
Sep 30, 2024 1.59 Mn
Jun 30, 2024 1.98 Mn
Mar 31, 2024 1.30 Mn
Dec 31, 2023 1.64 Mn
Sep 30, 2023 1.95 Mn
Jun 30, 2023 1.86 Mn
Mar 31, 2023 2.10 Mn
Dec 31, 2022 2.38 Mn
Sep 30, 2022 2.70 Mn
Jun 30, 2022 3.09 Mn
Mar 31, 2022 3.30 Mn
Jun 30, 2019 1.16 Mn
Mar 31, 2019 1.24 Mn